- Issuer ticker
-
BBNX
- Reported as of
-
16 Nov 2026
- Net transaction value
-
-$12,570
- SEC form
-
4
- Accepted by SEC
-
18 Nov 2026, 16:23:09 UTC
Filing notes and source
Key filing fact
Mark Hopman filed Form 4 for Beta Bionics, Inc. (BBNX) on 18 Nov 2026.
Key facts
- This page summarizes Mark Hopman's Form 4 filing for Beta Bionics, Inc. (BBNX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Nov 2026, 16:23.
Change
- Previous filing in this sequence was filed on 04 Nov 2026.
- Current net transaction value: -$12,570.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002048497
Primary reporting owner
Hopman Mark
- Relationship
-
Chief Commercial Officer
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BBNX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +775
- Change %
- +1.4%
- Price
-
$5.10*
- Shares after
- 54,918
- Date
- 16 Nov 2026
- Ownership
- Direct
BBNX
transaction
Common Stock
Sale
- Transaction value
- -$12,570
- Shares
- -775
- Change %
- -1.4%
- Price
-
$16.22
- Shares after
- 54,143
- Date
- 16 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BBNX
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -775
- Change %
- -3.6%
- Price
-
$0.000000*
- Shares after
- 20,950
- Date
- 16 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 775
- Exercise price
- $5.10
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses
2 footnotes